A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

S. G. Swinnen; M.-P. Dain; R. Aronson; M. Davies; H. C. Gerstein; A. F. Pfeiffer; F. J. Snoek; J. H. DeVries; J. B. Hoekstra; F. Holleman

doi:10.2337/dc09-2294

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

Diabetes Care ◽

10.2337/dc09-2294 ◽

2010 ◽

Vol 33 (6) ◽

pp. 1176-1178 ◽

Cited By ~ 101

Author(s):

S. G. Swinnen ◽

M.-P. Dain ◽

R. Aronson ◽

M. Davies ◽

H. C. Gerstein ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Treat To Target ◽

Oral Glucose ◽

Target Trial ◽

Once Daily ◽

Glucose Lowering

Download Full-text

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes

Diabetes Care ◽

10.2337/dc05-1365 ◽

2006 ◽

Vol 29 (6) ◽

pp. 1269-1274 ◽

Cited By ~ 452

Author(s):

K. Hermansen ◽

M. Davies ◽

T. Derezinski ◽

G. Martinez Ravn ◽

P. Clauson ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Detemir ◽

Treat To Target ◽

Oral Glucose ◽

Target Trial ◽

Nph Insulin ◽

Glucose Lowering

Download Full-text

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

Diabetologia ◽

10.1007/s00125-007-0911-x ◽

2008 ◽

Vol 51 (3) ◽

pp. 408-416 ◽

Cited By ~ 305

Author(s):

J. Rosenstock ◽

M. Davies ◽

P. D. Home ◽

J. Larsen ◽

C. Koenen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Treat To Target ◽

Target Trial ◽

Glucose Lowering

Download Full-text

A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70010-6 ◽

2007 ◽

Vol 2007 ◽

pp. 12-14

Author(s):

L. Kennedy

Keyword(s):

Type 2 Diabetes ◽

Insulin Detemir ◽

Treat To Target ◽

Oral Glucose ◽

Target Trial ◽

Nph Insulin ◽

Glucose Lowering

Download Full-text

Once-daily initiation of basal insulin as add-on to metformin: a 26-week, randomized, treat-to-target trial comparing insulin detemir with insulin glargine in patients with type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.12083 ◽

2013 ◽

Vol 15 (8) ◽

pp. 729-736 ◽

Cited By ~ 38

Author(s):

L. Meneghini ◽

J. Kesavadev ◽

M. Demissie ◽

A. Nazeri ◽

P. Hollander

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Insulin Detemir ◽

Treat To Target ◽

Target Trial ◽

Once Daily

Download Full-text

A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.11.001 ◽

2008 ◽

Vol 30 (11) ◽

pp. 1976-1987 ◽

Cited By ~ 106

Author(s):

Priscilla Hollander ◽

John Cooper ◽

Jesper Bregnhøj ◽

Claus Bang Pedersen

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Detemir ◽

Treat To Target ◽

Target Trial ◽

Open Label ◽

Parallel Group ◽

Mealtime Insulin ◽

Basal Bolus

Download Full-text

PDB56 THE IMPACT OF STARTING INSULIN GLARGINE VERSUS INSULIN DETEMIR ON QUALITY OF LIFE (QOL) AND TREATMENT SATISFACTION (TS) IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON ORAL GLUCOSE-LOWERING DRUGS (OGLDS)

Value in Health ◽

10.1016/s1098-3015(10)75034-8 ◽

2009 ◽

Vol 12 (7) ◽

pp. A412

Author(s):

SG Swinnen ◽

T Hajos ◽

F Holleman ◽

MP Dain ◽

JH DeVries ◽

...

Keyword(s):

Quality Of Life ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Satisfaction ◽

Insulin Detemir ◽

Oral Glucose ◽

Glucose Lowering ◽

The Impact

Download Full-text

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

Cardiovascular Diabetology ◽

10.1186/1475-2840-12-48 ◽

2013 ◽

Vol 12 (1) ◽

pp. 48 ◽

Cited By ~ 12

Author(s):

Alison R Meloni ◽

Mary Beth DeYoung ◽

Jenny Han ◽

Jennie H Best ◽

Michael Grimm

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Oral Glucose ◽

Glucose Lowering

Download Full-text

Insulin degludec compared with insulin glargine in insulin‐naïve patients with type 2 diabetes: A 26‐week, randomized, controlled, P an‐ A sian, treat‐to‐target trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12102 ◽

2013 ◽

Vol 4 (6) ◽

pp. 605-612 ◽

Cited By ~ 66

Author(s):

Yukiko Onishi ◽

Yasuhiko Iwamoto ◽

Soon Jib Yoo ◽

Per Clauson ◽

Søren C Tamer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec ◽

Treat To Target ◽

Target Trial ◽

Randomized Controlled

Download Full-text

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study

Diabetic Medicine ◽

10.1111/j.1464-5491.2006.01881.x ◽

2006 ◽

Vol 23 (7) ◽

pp. 736-742 ◽

Cited By ~ 144

Author(s):

H. C. Gerstein ◽

J.-F. Yale ◽

S. B. Harris ◽

M. Issa ◽

J. A. Stewart ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Trial ◽

Oral Glucose ◽

Glucose Lowering ◽

New Strategies

Download Full-text

Rationale, Design, and Baseline Data of the Insulin Glargine (Lantus) Versus Insulin Detemir (Levemir) Treat-To-Target (L2T3) Study: A Multinational, Randomized Noninferiority Trial of Basal Insulin Initiation in Type 2 Diabetes

Diabetes Technology & Therapeutics ◽

10.1089/dia.2009.0044 ◽

2009 ◽

Vol 11 (11) ◽

pp. 739-743 ◽

Cited By ~ 13

Author(s):

Sanne G.H.A. Swinnen ◽

Frank J. Snoek ◽

Marie-Paule Dain ◽

J. Hans DeVries ◽

Joost B.L. Hoekstra ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Basal Insulin ◽

Insulin Detemir ◽

Baseline Data ◽

Treat To Target ◽

Insulin Initiation ◽

Noninferiority Trial

Download Full-text